5-hydroxymethylcytosine has been researched along with Benign Neoplasms, Brain in 14 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 11 (78.57) | 24.3611 |
2020's | 3 (21.43) | 2.80 |
Authors | Studies |
---|---|
Cao, F; Hu, X; Liu, Y; Mao, Q; Xia, L; Xie, D; Yan, X; Yan, Z; Yin, S; Yuan, Y; Zhang, J; Zhang, S | 1 |
Li, C; Li, P; Li, S; Liu, P; Niu, Y; Tong, WM; Wang, B; Wu, T; Yang, Z; Zhang, J; Zhang, ZW; Zhao, F | 1 |
Aldape, K; Farooq, H; Glowacka, WK; Jain, H; Kongkham, P; Maimaitiming, A; Mamatjan, Y; Nejad, R; Okura, M; Taylor, MD | 1 |
Ding, Y; Fu, R; Guo, SW; Huang, KM; Li, DS; Luo, J; Tang, XJ | 1 |
Cain, JE; Jayasekara, WSN; St John, JC; Sun, X; Vaghjiani, V | 1 |
Astudillo, A; Bayón, GF; Bigot, T; Carella, A; Chiara, MD; Corte-Torres, MD; Fernández, AF; Fraga, MF; García, MG; García-Toraño, E; López, V; Mangas, C; Meléndez, B; Mollejo, M; Pérez, RF; Sáenz-de-Santa-María, I; Santamarina-Ojeda, P; Sierra, M; Tejedor, JR; Urdinguio, RG | 1 |
Li, L; Ye, C | 1 |
Akiyama, T; Ino, Y; Katou, Y; Koyama-Nasu, R; Kozuka-Hata, H; Masuda, K; Morishita, Y; Mukasa, A; Nasu-Nishimura, Y; Ogawa, H; Oyama, M; Saito, N; Sakaguchi, Y; Sato, T; Shirahige, K; Suzuki, T; Takai, H; Todo, T; Toyoshima, C | 1 |
Kriaucionis, S; McClellan, M; Schuster-Boeckler, B; Tomkova, M | 1 |
Cui, Y; Freeman, JL; Irudayaraj, J; Li, J; Liu, J; Liu, Q; Weng, L; Wirbisky, SE; Yuan, X | 1 |
Christensen, BC; Fadul, CE; Houseman, EA; Johnson, KC; King, JE; von Herrmann, KM | 1 |
Jiang, Y; Jin, SG; Krex, D; Lu, Q; Pfeifer, GP; Qiu, R; Rauch, TA; Schackert, G; Wang, Y | 1 |
Carell, T; Eigenbrod, S; Feiden, W; Globisch, D; Hackner, B; Kraus, TF; Kretzschmar, HA; Müller, M; Münzel, M; Pfaffeneder, T; Schüller, U; Wagner, M; Widmann, D | 1 |
Becker, A; Denkhaus, D; Freihoff, D; Freihoff, J; Gessi, M; Hammes, J; Isselstein, LJ; Luxen, D; Müller, T; Pietsch, T; Simon, M; Waha, A; zur Mühlen, A | 1 |
1 review(s) available for 5-hydroxymethylcytosine and Benign Neoplasms, Brain
Article | Year |
---|---|
5-hydroxymethylcytosine: a new insight into epigenetics in cancer.
Topics: 5-Methylcytosine; Animals; Brain Neoplasms; Cytosine; Dioxygenases; DNA Methylation; DNA-Binding Proteins; Epigenesis, Genetic; Humans; Leukemia; Mixed Function Oxygenases; Neoplasms; Proto-Oncogene Proteins | 2014 |
13 other study(ies) available for 5-hydroxymethylcytosine and Benign Neoplasms, Brain
Article | Year |
---|---|
Noninvasive detection of brain gliomas using plasma cell-free DNA 5-hydroxymethylcytosine sequencing.
Topics: 5-Methylcytosine; Brain; Brain Neoplasms; Glioma; Humans; Isocitrate Dehydrogenase; Mutation | 2023 |
Characterization of global 5-hydroxymethylcytosine in pediatric posterior fossa ependymoma.
Topics: 5-Methylcytosine; Adolescent; Brain Neoplasms; Carcinogenesis; Case-Control Studies; Cell Proliferation; Child; Child, Preschool; DNA Methylation; Ependymoma; Epigenomics; Female; Humans; Infant; Infratentorial Neoplasms; Ki-67 Antigen; Male; Prognosis; Proportional Hazards Models | 2020 |
5-Hydroxymethylcytosine preferentially targets genes upregulated in isocitrate dehydrogenase 1 mutant high-grade glioma.
Topics: 5-Methylcytosine; Adult; Aged; Brain Neoplasms; Cohort Studies; DNA Methylation; Female; Gene Expression Regulation, Neoplastic; Glioma; Humans; Isocitrate Dehydrogenase; Male; Middle Aged; Neoplasm Grading; RNA, Messenger; Up-Regulation | 2018 |
Ten-eleven translocation 1 regulates methylation of autophagy-related genes in human glioma.
Topics: 5-Methylcytosine; Autophagy; Brain; Brain Neoplasms; Cell Line, Tumor; DNA Methylation; Glioma; Humans; Mixed Function Oxygenases; Neoplasm Grading; Proto-Oncogene Proteins | 2018 |
The degree of mitochondrial DNA methylation in tumor models of glioblastoma and osteosarcoma.
Topics: 5-Methylcytosine; Animals; Bone Neoplasms; Brain Neoplasms; Cell Line, Tumor; DNA Copy Number Variations; DNA Methylation; DNA, Mitochondrial; Genotype; Glioblastoma; Humans; Immunoprecipitation; Mice; Mitochondria; Neoplasm Transplantation; Osteosarcoma; Whole Genome Sequencing | 2018 |
Epigenetic downregulation of TET3 reduces genome-wide 5hmC levels and promotes glioblastoma tumorigenesis.
Topics: 5-Methylcytosine; Animals; Biopsy; Brain Neoplasms; Carcinogenesis; Cell Line, Tumor; Dioxygenases; DNA Methylation; Down-Regulation; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Glioblastoma; Histone Code; Humans; Mice; Prognosis; RNA, Messenger; Survival Analysis; Xenograft Model Antitumor Assays | 2020 |
5-Hydroxymethylcytosine plays a critical role in glioblastomagenesis by recruiting the CHTOP-methylosome complex.
Topics: 5-Methylcytosine; Acetylation; Brain Neoplasms; Carcinogenesis; Chromatin; Cytosine; DNA-Binding Proteins; Gene Expression Regulation, Neoplastic; Glioblastoma; HEK293 Cells; Histones; Humans; Methylation; Mixed Function Oxygenases; Nuclear Proteins; Protein-Arginine N-Methyltransferases; Proto-Oncogene Proteins; Repressor Proteins; Transcription Factors; Transcription, Genetic | 2014 |
5-hydroxymethylcytosine marks regions with reduced mutation frequency in human DNA.
Topics: 5-Methylcytosine; Brain Neoplasms; CpG Islands; Databases, Genetic; DNA Methylation; DNA, Neoplasm; Epigenesis, Genetic; Exome Sequencing; Humans; Kidney Neoplasms; Mutation Rate; Myelodysplastic Syndromes; Myeloid Cells | 2016 |
Regulatory landscape and clinical implication of MBD3 in human malignant glioma.
Topics: 5-Methylcytosine; Brain Neoplasms; Cell Line, Tumor; Disease-Free Survival; DNA-Binding Proteins; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Glioma; High-Throughput Nucleotide Sequencing; HLA-D Antigens; Humans; MicroRNAs; Oligonucleotide Array Sequence Analysis; Pilot Projects; RNA Interference; RNA, Long Noncoding; RNA, Untranslated; Signal Transduction; Time Factors; Transcription, Genetic; Transfection | 2016 |
5-Hydroxymethylcytosine localizes to enhancer elements and is associated with survival in glioblastoma patients.
Topics: 5-Methylcytosine; Adult; Aged; Aged, 80 and over; Brain Neoplasms; DNA Methylation; DNA, Neoplasm; Enhancer Elements, Genetic; Female; Gene Expression Regulation, Neoplastic; Gene Regulatory Networks; Glioblastoma; Humans; Isocitrate Dehydrogenase; Male; Middle Aged; Prefrontal Cortex; Survival Analysis; Transcription Factors | 2016 |
5-Hydroxymethylcytosine is strongly depleted in human cancers but its levels do not correlate with IDH1 mutations.
Topics: 5-Methylcytosine; Animals; Base Sequence; Brain; Brain Neoplasms; Carcinoma, Squamous Cell; Cell Line, Tumor; Chromatography, Liquid; Cytosine; DNA-Binding Proteins; DNA, Neoplasm; Female; Gene Expression Regulation, Neoplastic; HEK293 Cells; Humans; Immunohistochemistry; Isocitrate Dehydrogenase; Lung Neoplasms; Male; Mice; Mixed Function Oxygenases; Molecular Structure; Mutation; Neoplasms; Proto-Oncogene Proteins; Reverse Transcriptase Polymerase Chain Reaction | 2011 |
Low values of 5-hydroxymethylcytosine (5hmC), the "sixth base," are associated with anaplasia in human brain tumors.
Topics: 5-Methylcytosine; Adolescent; Adult; Aged; Aged, 80 and over; Anaplasia; Astrocytoma; Brain; Brain Neoplasms; Cerebral Cortex; Child; Child, Preschool; Cytosine; DNA; Epigenesis, Genetic; Female; Humans; Isocitrate Dehydrogenase; Male; Middle Aged; Mutation; Young Adult | 2012 |
Nuclear exclusion of TET1 is associated with loss of 5-hydroxymethylcytosine in IDH1 wild-type gliomas.
Topics: 5-Methylcytosine; Brain Neoplasms; Cell Line, Tumor; Cell Nucleus; Cytosine; Dioxygenases; DNA Methylation; DNA Modification Methylases; DNA Repair Enzymes; DNA-Binding Proteins; Dual-Specificity Phosphatases; Female; Gene Expression Regulation, Enzymologic; Glioblastoma; Glioma; Humans; Immunohistochemistry; Isocitrate Dehydrogenase; Male; Mitogen-Activated Protein Kinase Phosphatases; Mixed Function Oxygenases; Mutation; Proto-Oncogene Proteins; Real-Time Polymerase Chain Reaction; RNA, Messenger; Sequence Analysis, DNA; Subcellular Fractions; Tumor Suppressor Proteins | 2012 |